Bayraktar M - Search Results

1

Serum immunoglobulin E and soluble CD23 in patients with Graves' disease.

Sayinalp S, Akalin S, Sayinalp N, Erbaş T, Bayraktar M, Ozcebe OI, Dündar S, Kirazli S. Sayinalp S, et al. Among authors: bayraktar m. Horm Metab Res. 1996 Mar;28(3):133-7. doi: 10.1055/s-2007-979145. Horm Metab Res. 1996. PMID: 8926012 Clinical Trial.

2

The effect of radioactive iodine treatment on thyroid C cells.

Bayraktar M, Gedik O, Akalin S, Usman A, Adalar N, Telatar F. Bayraktar M, et al. Clin Endocrinol (Oxf). 1990 Nov;33(5):625-30. doi: 10.1111/j.1365-2265.1990.tb03901.x. Clin Endocrinol (Oxf). 1990. PMID: 2253413

3

A preliminary report of thyroglobulin release after fine needle aspiration biopsy of thyroid nodules.

Bayraktar M, Ergin M, Boyacioglu A, Demir S. Bayraktar M, et al. J Int Med Res. 1990 May-Jun;18(3):253-5. doi: 10.1177/030006059001800312. J Int Med Res. 1990. PMID: 2361565

4

Platelet factor 4, beta-thromboglobulin and thrombospondin levels in type I diabetes mellitus patients.

Bayraktar M, Dündar S, Kirazli S, Teletar F. Bayraktar M, et al. J Int Med Res. 1994 Mar-Apr;22(2):90-4. doi: 10.1177/030006059402200204. J Int Med Res. 1994. PMID: 8020643

5

Intracellular magnesium depletion relates to increased urinary magnesium loss in type I diabetes.

Gürlek A, Bayraktar M, Ozaltin N. Gürlek A, et al. Among authors: bayraktar m. Horm Metab Res. 1998 Feb;30(2):99-102. doi: 10.1055/s-2007-978844. Horm Metab Res. 1998. PMID: 9543693

6

Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels.

Gürlek A, Bayraktar M, Kirazli S. Gürlek A, et al. Among authors: bayraktar m. Diabetes Care. 2000 Jan;23(1):88-92. doi: 10.2337/diacare.23.1.88. Diabetes Care. 2000. PMID: 10857975

7

Multifocal idiopathic fibrosclerosis manifesting with Riedel's thyroiditis.

Tütüncü NB, Erbas T, Bayraktar M, Gedik O. Tütüncü NB, et al. Among authors: bayraktar m. Endocr Pract. 2000 Nov-Dec;6(6):447-9. Endocr Pract. 2000. PMID: 11155216

8

Global fibrinolytic capacity is decreased in polycystic ovary syndrome, suggesting a prothrombotic state.

Yildiz BO, Haznedaroğlu IC, Kirazli S, Bayraktar M. Yildiz BO, et al. Among authors: bayraktar m. J Clin Endocrinol Metab. 2002 Aug;87(8):3871-5. doi: 10.1210/jcem.87.8.8716. J Clin Endocrinol Metab. 2002. PMID: 12161525

9

Liver tests in hyperthyroidism: effect of antithyroid therapy.

Gürlek A, Cobankara V, Bayraktar M. Gürlek A, et al. Among authors: bayraktar m. J Clin Gastroenterol. 1997 Apr;24(3):180-3. doi: 10.1097/00004836-199704000-00013. J Clin Gastroenterol. 1997. PMID: 9179740

10

Abnormalities in measures of liver function and injury in thyroid disorders.

Bayraktar M, Van Thiel DH. Bayraktar M, et al. Hepatogastroenterology. 1997 Nov-Dec;44(18):1614-8. Hepatogastroenterology. 1997. PMID: 9427032 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

197 results

Search Page

Filters